首页 / 院系成果 / 成果详情页

A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity. 会议论文

编号：

211cad0a-0814-4c7c-b790-6af584b8d13e
作者：

Gong, Jifang; Liu, Tianshu; Fan, Qingxia; Bai, Li; Bi, Feng; Qin, Shukui; Wang, Jinwan; Xu, Nong; Cheng, Ying; Bai, Yuxian; Liu, Wei; Wang, Liwei; Shen, Lin
作者单位：

Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China; Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; Beijing 301 PLA Hosp, Beijing, Peoples R China; Sichuan Univ, Dept Med Oncol, West China Hosp, Chengdu 610064, Peoples R China; Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China; Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; Jilin Prov Canc Hosp, Changchun, Peoples R China; Heilongjiang Prov Canc Hosp, Harbin, Peoples R China; Hebei Tumor Hosp, Shijiazhuang, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
会议名称：

JOURNAL OF CLINICAL ONCOLOGY
会议时间：
出版信息：

2014 年 32 卷 3 期

浏览次数：4  下载次数：0

浏览次数：4

下载次数：0

打印次数：0